Abstract: A manufacturing process of a heat-resisting glass or enamel coating of a thermally insulated container chamber is described. The process comprises selecting a thermally insulated metal container body, and performing sand blasting to a chamber surface of the body such that the chamber surface becomes a rough surface. The process comprises spraying a glass or enamel glazing material on the rough surface of the body and drying the glazing material on the rough surface. The process comprises placing a dried body on a bracket and sintering the dried body. After sintering is performed, the process comprises removing the body from the bracket. Using this disclosure the chemical properties of the glass coating or enamel coating are relatively stable, so corrosion will not occur. Because the thermal expansion and cold contraction are relatively small, the coating is suitable for manufacturing thermally insulated containers such as thermally insulated cups.

Abstract: A manufacturing process of a heat-resisting glass or enamel coating of a thermally insulated container chamber is described. The process comprises selecting a thermally insulated metal container body, and performing sand blasting to a chamber surface of the body such that the chamber surface becomes a rough surface. The process comprises spraying a glass or enamel glazing material on the rough surface of the body and drying the glazing material on the rough surface. The process comprises placing a dried body on a bracket and sintering the dried body. After sintering is performed, the process comprises removing the body from the bracket. Using this disclosure the chemical properties of the glass coating or enamel coating are relatively stable, so corrosion will not occur. Because the thermal expansion and cold contraction are relatively small, the coating is suitable for manufacturing thermally insulated containers such as thermally insulated cups.

Abstract: A reagent and method for the specific and highly sensitive detection of C. parvum in which the reagent is an antibody for a soluble C. parvum sporozoite antigen and the method is an immunoassay in which the antibody is used to detect or quantify C. parvum sporozoite antigen in a sample. The sample is treated to cause excystation of C. parvum oocytes, thereby releasing a C. parvum sporozoite antigen, and combined with antibodies specific for the sporozoite antigen under conditions to form an antibody-antigen complex. Detection of the complex indicates the presence of C. parvum in the sample. The assay allows recognition and detection of C. parvum in turbid samples, and due to a lack of crossreactivity with other Cryptosporidium species, is specific for C. parvum contamination or infection. The assay is highly sensitive, allowing for the detection of less than 100 oocysts per milliliter of sample.

Abstract: Compositions and methods for the detection of Taenia solium and the diagnosis of T. solium infection are described. The nucleotide and amino acid sequences of the antigenic T. solium polypeptides gp50a, gp50b and gp50c are provided. The compositions contain synthetic antigenic polypeptides of larval origin prepared using the sequences described herein. Probes and primers for the detection or amplification of T. solium nucleic acid molecules are also described. The polypeptides can be administered to a human or animal to protect against T. solium infection. In addition, the polypeptides are useful as research tools for studying T. solium and as reagents in assays for the detection of T. solium antibodies in a biological sample. The methods are sensitive and specific assays that utilize the stable recombinant or synthetic antigenic polypeptides or nucleic acid molecules encoding the larval polypeptides.

Abstract: The present disclosure relates to T24 nucleic acid sequences, amino acid sequences, and antibodies. Methods for detecting and diagnosing Taenia solium infection in a subject using the T24 sequences and specific binding agents are also disclosed. The T24 sequences disclosed herein can be formulated into a pharmaceutical composition for administration to a subject. For example, the disclosed T24 polypeptides can also be administered to a subject to stimulate an immune response in the subject, thereby protecting the subject against T. solium infection.